Navigation Links
Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
Date:4/29/2008

CAMBRIDGE, Mass., April 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the first quarter ended March 31, 2008. At March 31, 2008, Idenix's cash, cash equivalents and marketable securities totaled approximately $99.0 million.

2008 Year-to-Date Business Highlights

-- Idenix reported positive data from an ongoing phase I/II study of

IDX899, a non-nucleoside reverse transcriptase inhibitor (NNRTI) being

developed for the treatment of HIV-1. In the first dosing cohort of

this study, eight HIV-1 infected treatment-naive patients receiving 800

mg of IDX899 once-daily achieved a median reduction in plasma virus

levels of approximately 2.0 log10, or 99 percent, after seven days of

treatment. The 400 mg cohort of this study is now complete and dosing

has been initiated in the 200 mg cohort. To date, no serious adverse

events have been reported and no patients have discontinued from the

study. Data from this clinical trial have been submitted for

presentation at scientific meetings this summer.

-- The company continued to make progress with its hepatitis C discovery

and development programs, having presented data from preclinical

studies of its lead nucleotide prodrug candidate, IDX184, and potential

clinical candidates from its protease inhibitor program at the annual

meeting of the European Association for the Study of the Liver (EASL)

last week. (Please see Idenix press releas
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
2. Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
3. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
4. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
5. Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
6. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
7. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
9. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
10. Celator(R) Pharmaceuticals Successfully Uses Nanoparticles to Administer Hydrophobic Drug Combinations
11. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Diomics today announced that ... senior official, has joined the company,s board of directors, ... Intelligence Studies Project and Clinical Professor at the Lyndon ... of Texas at Austin. "Steve brings ... served 28 years as a member of CIA,s clandestine ...
(Date:6/3/2015)... CORONA, Calif. , June 3, 2015  Giving ... is the ultimate mission of the International Academy ... offer treatments and resources that are at the forefront ... eye care professionals in the technology and latest treatment ... that has not been remedied with traditional means. Recently, ...
(Date:6/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/t3kkhg/the_future_of ) has ... of Pharmaceutical Outsourcing" report to their offering. ... need to develop better drugs with high success ... increasingly utilizing external resources to increase their efficiency ... internal operation. Their outsourcing demands and proportions have ...
Breaking Medicine Technology:Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4The Future of Pharmaceutical Outsourcing: 2015 Report 2
... (NYSE: AME ) today announced that it ... of custom, fine-featured components used in the medical device ... in Montevideo, MN, has annual sales of approximately $25 ... of businesses that serve the highly attractive medical device ...
... NEW YORK, April 28, 2011 Reportlinker.com ... is available in its catalogue: ... Healthcare System and Drug Regulatory Overview: Cost-containment ... http://www.reportlinker.com/p0487111/Pharmaceutical-Key-Trends-2011---Healthcare-System-and-Drug-Regulatory-Overview-Cost-containment-and-regulatory-pressures-intensify.html ...
Cached Medicine Technology:AMETEK ACQUIRES AVICENNA TECHNOLOGY 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 2Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 3Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 4Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 5Reportlinker Adds Pharmaceutical Key Trends 2011 - Healthcare System and Drug Regulatory Overview: Cost-containment and regulatory pressures intensify 6
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... June 03, 2015 Array Health ... technology, has announced that CEO Jonathan Rickert will present ... on June 4, 2015. The session will address ... are disrupting traditional business models in health care, and ... , WHAT: Digital Transformation and the Health Care ...
(Date:6/3/2015)... 2015 A group of nine authors ... a Global Inspire Award at DIA’s upcoming Annual Meeting. ... volunteers for their leadership, level of excellence, and commitment ... The recipients of the Author(s) of the Year Award, ... article has made a significant impact in advancing medical ...
(Date:6/3/2015)... 2015 Z-Medica®, LLC, a leading developer ... has been designated as National Safety Month by the ... Police Department for its commitment to public safety. ... Individual First Aid Kits (IFAK) over 100 times in ... stabbings or traffic accidents. Each kit is equipped with ...
(Date:6/3/2015)... NC (PRWEB) June 03, 2015 Researchers ... two biomarkers for mesothelioma and say the tried-and-true marker ... just posted an article on the research. Click ... the University’s National Center for Asbestos Related Diseases say, ... positive results, it is still preferable to fibulin-3 for ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Z-Medica Commends Tucson Police Department for Trauma Kit Utilization 2Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2
... Secretary of State Colin Powell, a strong advocate for national ... the world and call upon them to continue their efforts ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20081014/DC38855LOGO ) ... the importance and value of volunteerism as part of the ...
... FDA compliant solution that works within minutes to relieve the ... on stings caused by the Portuguese man-of-war. Jellyfish Squish(TM) ... can be purchased online and at select stores including drug ... of 2009 Dr. Peter Verity, a world renowned marine biologist ...
... August and September, PF Week Sept. 14 - 21 ... for Pulmonary Fibrosis (CPF) announced today it has scheduled its 2009 ... The primary goals of this year,s activity are to ensure passage ... of Congress and in communities nationwide. , , Specifically, the ...
... ... ... National HIV Testing Day, June 27, by encouraging people of all ages to learn about HIV, ... vaginal fluids or breast milk. Exposure to any of these fluids can put you at ...
... and Medicare plan participants in Ga. now have access ... , June 25 UnitedHealthcare and ... services of Fusion Sleep,s sleep disorder program available to ... , , "Fusion Sleep provides a very important ...
... French . , Montreal, June 25th 2009 ... have two choices: inject them with medication to dissolve the ... open the blocked artery (primary percutaneous coronary intervention (PCI)). Guidelines ... that do not take "real-life" conditions into account. The latest ...
Cached Medicine News:Health News:Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 2Health News:Popular Jellyfish Sting Treatment Also Proven Effective on Stings From Portuguese Man-of-War 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:Planned Parenthood Recognizes National HIV Testing Day 2Health News:UnitedHealthcare and Fusion Sleep Announce New Agreement 2Health News:Research: Improving treatment of patients with heart attack 2
...
... A wide range of miniTHERM incubators is ... appropriate application solution for their specific requirements. ... liters, are compact and extremely space saving. ... microwave oven. It is possible to stack ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
... miniTHERM incubators is available, ensuring the customers ... their specific requirements. miniTHERM incubators have a ... extremely space saving. Their size corresponds approximately ... possible to stack up to three units ...
Medicine Products: